CDCA7: Cell Division Cycle Associated 7

A key regulator of cell proliferation and MYC target gene involved in hematological malignancies and ICF syndrome

Gene Information Card

Symbol CDCA7
Full Name Cell Division Cycle Associated 7
Gene Type Protein coding
Chromosomal Location 2q31.1
NCBI Gene ID 83879 ncbi.nlm.nih.gov/gene/83879
Ensembl ID ENSG00000144354
UniProt ID Q9BWT1
OMIM ID 609937
HGNC ID 14628
Aliases JPO1, MGC117188

Description

CDCA7 (Cell Division Cycle Associated 7) is a protein-coding gene that encodes a nuclear protein involved in cell cycle regulation and transcriptional control. It is a direct target of the MYC oncogene and plays a role in cell proliferation, DNA replication, and chromatin remodeling. Mutations in CDCA7 are associated with immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome type 3. The gene is also implicated in various cancers, particularly hematological malignancies.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Immunodeficiency-centromeric instability-facial anomalies syndrome 3 (ICF3) Loss-of-function mutations in CDCA7 disrupt DNA methylation and chromatin stability, leading to immune deficiency and developmental abnormalities. ClinVar, OMIM
Acute myeloid leukemia (AML) Overexpression of CDCA7 driven by MYC contributes to leukemogenesis by promoting cell proliferation. COSMIC, NCBI
Lymphoma CDCA7 is upregulated in B-cell lymphomas and may act as an oncogene downstream of MYC. COSMIC, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Bone marrow 12.5 Medium
Lymph node 8.3 Medium
Testis 6.7 Low
Spleen 5.9 Low
Thymus 4.8 Low
Cell Line Expression
Cell Line nTPM Notes
K562 (leukemia) 15.2 High expression; consistent with MYC target role
HeLa (cervical cancer) 10.1 Moderate expression
HEK293 (embryonic kidney) 7.4 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.169C>T (p.Arg57*) Nonsense Rare Loss of function; associated with ICF3
c.325G>A (p.Gly109Arg) Missense Rare Likely loss of function; reported in ICF3
c.1A>G (p.Met1?) Start loss Rare Loss of function; ICF3
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and start-loss mutations in CDCA7 cause loss of protein function, leading to ICF syndrome type 3.

Gain of Function (GOF)

Not reported; overexpression in cancer is likely due to upstream MYC activation rather than activating mutations.

Dominant Negative (DN)

Not described for CDCA7.

Pathways

MYC transcriptional activation of cell cycle genes
DNA methylation and chromatin remodeling (ICF pathway)

Protein Summary

The CDCA7 protein is a nuclear factor of 371 amino acids (UniProt Q9BWT1) that contains a conserved C-terminal domain involved in chromatin binding. It is a direct transcriptional target of MYC and participates in cell cycle progression and DNA replication. CDCA7 interacts with the chromatin remodeling complex HELLS, which is essential for DNA methylation maintenance. Loss of CDCA7 function leads to hypomethylation of pericentromeric repeats and immune dysfunction characteristic of ICF syndrome.

Related Products

Product name Cat.No. Species Gene ID
CDCA7 Knockout HEK293 Cell Line EDJ-KQ9916 Human 83879 Details Get a Quote
CDCA7L Knockout HEK293 Cell Line EDJ-KQ12081 Human 55536 Details Get a Quote
CDCA7L Knockout A-549 Cell Line EDJ-KQ41984 Human 55536 Details Get a Quote
CDCA7L Knockout HCT 116 Cell Line EDJ-KQ41986 Human 55536 Details Get a Quote
CDCA7L Knockout HeLa Cell Line EDJ-KQ41987 Human 55536 Details Get a Quote
CDCA7 Knockout A-549 Cell Line EDJ-KQ36817 Human 83879 Details Get a Quote
CDCA7 Knockout HCT 116 Cell Line EDJ-KQ36818 Human 83879 Details Get a Quote
CDCA7 Knockout HeLa Cell Line EDJ-KQ36819 Human 83879 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: